Plasmodium falciparum in culture grows optimally at 3% oxygen. Oxygen levels down to 0.5% still support growth, but anaerobic conditions do not. These findings, and the absence of the Krebs cycle in Plasmodium, suggested that in this organism oxygen may not function in electron transport but rather may act through metalloprotein oxygenases. Tetraethylthiuram disulfide (Antabuse, disulfiram) and its reduction product diethyldithiocarbamate inhibit many metalloprotein oxygenases and have a lipid/H20 partition coefficient and high binding constant for metal ions, favoring selective toxicity to the malaria parasite. These compounds exhibited active antimalarial effects in vitro in concentrations down to 0.1 ,g/ml, the lowest level tested. Tetraethylthiuram disulfide at a level as low as 1 pg/ml inhibited parasite glycolysis with no effect on glycolysis of normal erythrocytes. Erythrocytes pretreated with this drug at 10 pg/ml did not support growth of the parasite.
Plasmodium falciparum, when cultured in vitro (1) , has been shown to be a microaerophile, growing best at 3% 02 but tolerating 02 levels as low as 0.5% without appreciable reduction in multiplication rates (2) . However, there does appear to be a critical level of 02 below which the parasite will not survive, in contrast to true anaerobic forms of life. It has been known for some time that the malaria parasite does not use the Krebs cycle to degrade its glucose completely to CO2 and H20 but instead excretes organic end products (3, 4) . This suggests that the parasite may depend on reactions involving oxygenases and hydroxylases in which 02 is a chemical reactant (5) . These oxidations are catalyzed by oxidase enzymes or enzyme systems that activate the 02 and oxidize the substrate. Oxidases are often metalloproteins, containing metals such as iron, copper, or molybdenum, and are present in microorganisms, plants, and animals (6) . Therefore, we felt, first, that a chelating agent with activity against such metalloproteins might have selective toxicity to malaria parasites without interference with the cellular metabolism of the host tissues. One type of agent emerges from the rest with high probability of achieving this objective, the dialkyldithiocarbamates and their dimers, the thiuram disulfides. Diethyldithiocarbamate (DDC) is a chelating agent with proven inhibitory activity against many of these enzymes (7) . There is no sharp distinction among the alkyl dithiocarbamoyl compounds, and they can be transformed into each other in nutrient solutions (8) . Dimethyldithiocarbamate is strongly fungotoxic, particularly to fungi with obligatory aerobic metabolism. Fortunately, higher plants and vertebrate animals possessing an obligatory aerobic type of metabolism show little or no response to these substances (7, 9, 10) . The diethyl derivative (Antabuse, disulfiram) is even lesis toxic to mammals (11) , and, in clinical trials, single doses of up to 6 g and daily doses of 0.25-0.60 g for several months produced no
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. effects apart from those following ingestion of alcohol. Therefore it has received attention in aversion therapy in the treatment of alcoholics (12) , as well as heavy metal poisoning (7) . Second, these compounds exhibit lipid/H20 partition coefficients favoring penetration (7) . This is an important consideration because the compound must penetrate the erythrocyte membrane, equilibrate with the erythrocyte cytoplasm, then traverse the parasitophorous vacuole membrane and space, and finally penetrate the limiting membranes of the intracellular parasite and possibly even subcellular organelles. Increasing the hydrocarbon chain of the alkyl groups or introducing aryl groups increases the lipophilic characteristics of the drug molecule but unfortunately decreases activity, probably due to steric hindrance (9) . Last, these compounds have favorable binding constants enabling them to compete effectively with naturally occurring chelators in the cell for metal ions (13) (14) (15) . Therefore, on the basis of these favorable parameters one would expect DDC and its dimeric oxidation product tetraethylthiuram disulfide (TETD) to exhibit highly selective inhibitory activity toward the malaria parasite P.
falciparum.
MATERIALS AND METHODS P. falciparum, strain FCR3/FMG (Gambian strain) (16) was grown in vitro in 8% erythrocyte suspensions by using the petri dish-candle jar method as described by Jensen and Trager (17) . Type A erythrocytes and sera were used throughout the study. Four petri dishes of parasites were grown at each drug concentration unless otherwise specified. The media and parasitized erythrocytes were dispensed into petri dishes and parasites were allowed to multiply in the absence of drug for 24 by. a modification of the method of Lowry et al. (19) . Lactate dehydrogenase (Worthington) used in this assay was diluted with 0.9% NaCl rather than albumin and the buffer used was 2-amino-4-methyl-1-propanol, pH 9.7. Pyruvate was determined according to the method of Bucher et al. (20) except for the substitution of 0.5 M glycylglycine buffer in place of 0.4 M triethanolamine buffer. Glucose was assayed spectrophotometrically at-340 nm by a modified method of Slein (21) . The reaction mixture contained 40 Studies involving "pretreated" erythrocytes utilized uninfected erythrocytes stored in the refrigerator in TETD at a total concentration of 10 ,ug/ml for 24 hr. These were then washed three times in a 2-fold excess of drug-free medium and mixed with concentrated samples of predominantly schizonts separated in gelatin (22) With TETD at 10 ,gg/ml, there was only a 44% inhibition of glucose utilization, significantly less than the 70% inhibition achieved with TETD at 1 ,g/ml. This is termed "concentration quenching" or "biphasic response" (15) and in general agrees with the results reported by others on pyruvate production in fungi in the presence of these compounds (24, 25) . This is determined by the type of complex formed between chelator and 116 Parasites were grown in.4-ml petri dishes to a 7% parasitemia. Slides were made to assess parasitemia. TETD was added in specified concentrations, each accompanied by a Me2SO control. Zero time dishes were immediately harvested. Growth in the remaining dishes was allowed to continue for 6 hr, and the supernatants were removed for analysis. Fresh media containing TETD or Me2SO were added and parasites were allowed to grow an additional 16 hr. Slides were made for all petri dishes to assess growth and morphology. All reactions were stopped by the addition of perchloric acid to a final concentration of 3%. This is the result of one of two similar experiments. * Controls contained the same amount of Me2SO as was introduced with the stated concentration of TETD. growth of P. falciparum (Table 4 ). This suggests the lipophilic drug may accumulate on or in the erythrocytes, preventing them from supporting growth of the malaria parasite. When the experiment was done with erythrocytes incubated in TETD for 24 hr at 380C and subsequently treated as were those pretreated in the refrigerator, the inhibition was less dramatic. This apparent discrepancy is not yet explained. DISCUSSION TETD is a relatively safe compound used clinically to treat alcohol abuse patients by aversion therapy (30) . It is thought that this drug sensitizes them to alcohol presumably through inhibition of aldehyde oxidase. Failure to abstain from ethanolic beverages results in a rise of serum acetaldehyde and a wide variety of unpleasant systemic manifestations (31) , which encourages abstinence from spirits. It is interesting to note that inordinately high doses (500-1000 mg/kg) DDC injected intravenously have been reported to damage islets of Langerhans in experimental animals, thereby causing diabetes (32), probably by reacting with the Zn2+ in the islet cells. However, doses of sodium DDC required to produce hyperglycemia were 500-1000 mg/kg, and the hyperglycemia was only temporary in 11 out of 15 animals. The lethal dose of TETD is 3 g/kg body weight (12, 33) , but lower doses are relatively nontoxic apart from those symptoms seen after ingestion of alcohol.
Our studies demonstrate that low doses of TETD and its reduction product, DDC, are highly inhibitory to growth of the human malaria parasite P. falciparum. This is consistent with the finding that the closely related compound tetramethylthiuram disulfide and its carbamate reduction product are more toxic to parasitic molds than to saprophytic fungi (10) . In addition, the glycolysis of the malaria parasite appears specifically sensitive to low doses of TETD, in contrast to glycolysis in the host erythrocyte. This may result from differential sensitivity of host and parasite glycolytic enzymes, or less directly as a consequence of higher than usual methemoglobin concentration, which is known to be present in malarial erythrocytes (34) . TETD is rapidly and almost quantitatively reduced to DDC (35) (36) (37) , presumably through the glutathione/glutathione reductase system of erythrocytes (37, 38) , in many in vitro systems and in vivo. The reduction can be demonstrated spectrophotometrically at 450 nm (26, 39) and occurs in our in vitro cultivation system, indicating that the chemical moiety DDC is in fact generated in our system. It is known that methemoglobin promotes oxidation of DDC to TETD (35, 36) and TETD but not DDC is a potent inhibitor of hexokinase (35) . Therefore, cells high in methemoglobin such as the P. falclparum-infected cells in culture would be sensitive to TETD inhibition of glycolysis, presumably at hexokinase. In any case, it seems likely that the growth inhibition exerted by DDC and TETD does not stem mainly from its effect on glycolysis.
Malaria parasites free from host cell contamination have been shown to be rich in cytochrome oxidase, a metalloprotein (3, 40, 41) . Our unpublished studies also show that P. falciparum is extremely sensitive to KCN at concentrations to 5 ,uM in vitro.
It is known that many metalloprotein oxidases in addition to cytochrome oxidase are inactivated by cyanide (42) . In contrast, the dithiocarbamates show no effect on the cytochrome system (43) and affect 02 consumption only in concentrations that far exceed those that inhibit growth of organisms in test systems (8) . Therefore the inhibition of the growth of malaria parasites observed in this study is not likely due to inhibition of terminal electron transport reactions in this organism.
In contrast to the potent in vitro activity of this drug in our studies, serum drawn from volunteers on therapeutic doses of TETD was not inhibitory to P. falciparum in culture at a 50% serum/medium mixture. Drug concentrations reported to be circulating in patients taking TETD fall within the "parasiticidal" limits seen in our growth studies. It has been reported that the therapeutic dose of 250-500 mg per day in humans results in a "plasma" concentration of 0.5-1.0 mg/100 ml, and the drug persists in pharmacologically active levels for about 6 days (28) . Because TETD in concentrations as little as 1:1,000,000 (10-7 M) in vitro totally inhibits acetaldehyde oxidase of rabbit and rat liver (44, 45) , the unusually high plasma concentration of the drug reported must be reexamined. Our studies suggest that human erythrocytes treated with levels of TETD reported as circulating in patients taking this drug did not support growth of parasites as long as 6 days later. This indicates that the erythrocytes are changed in some way by TETD, maldng them inhospitable to the parasites. It remains to be seen if erythrocytes taken from patients receiving the drug would also have resisted infection, because the work of Linderholm and Berg (29) suggests that all of the DDC is found in erythrocytes of humans taking TETD.
